Serina Therapeutics, Inc.

SER

$2.69

+2.67%

N/A+$0.07

Healthcare

Biotechnology

AMEX

Active Trading

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, ...

Insider Transactions of SER

Acquisitions (A)

Since Jun 17, 2026

Disposals (D)

Since Jun 17, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jul 22, 2026	Simon Farrell	director	Stock Option (right to buy)	A	30,500	$2.17
Jul 22, 2026	Simon Farrell	director:	—	—	0	—
Jul 7, 2026	Brannan Stephen K.	director	Common Stock	A	1,000	$2.03
Jun 17, 2026	Venkatesan Jay	director	Common Stock	A	224,152	$2.25
Jun 17, 2026	Venkatesan Jay	director	Stock Option (right to buy)	A	15,250	$1.98

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

12,056,957

Total Shares Sold

96,525

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Bailey Gregory

director • 4 txns

Venkatesan Jay

director • 3 txns

Simon Farrell

director • 2 txns

Brannan Stephen K.

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jul 22, 2026	Simon Farrell	director	Stock Option (right to buy)	A	30,500	$2.17	$66,185.00
Jul 22, 2026	Simon Farrell	director:	—	—	0	—	—
Jul 7, 2026	Brannan Stephen K.	director	Common Stock	A	1,000	$2.03	$2,030.00
Jun 17, 2026	Venkatesan Jay	director	Common Stock	A	224,152	$2.25	$504,342.00
Jun 17, 2026	Venkatesan Jay	director	Stock Option (right to buy)	A	15,250	$1.98	$30,195.00
Jun 17, 2026	Venkatesan Jay	director	Series A Convertible Preferred Stock	D	96,525	$5.18	$499,999.50
Jun 17, 2026	Bailey Gregory	director	Common Stock	A	6,666,667	$2.25	$14,999,334.08
Jun 17, 2026	Bailey Gregory	director	Redeemable Warrants	A	3,333,333	$5.00	$16,666,665.00
Jun 17, 2026	Bailey Gregory	director	Common Stock	A	1,770,805	$2.25	$3,984,311.25
Jun 17, 2026	Bailey Gregory	director	Stock Option (right to buy)	A	15,250	$1.98	$30,195.00

Upstream

Enable Injections, Inc.Contract Development & Manufacturing Organizations (CDMOs) — API & Drug ProductHudsonAlpha Institute for BiotechnologyMerck KGaA (Sigma-Aldrich)XETRA:MRKThe Scripps Research InstituteRaw Chemical & Monomer Suppliers

Downstream

Pfizer Inc.NYSE:PFEEnable Injections, Inc.Neuroscience Trials Australia (NTA)Parkinson's AustraliaAstraZeneca plcNASDAQ:AZN

Proxies

Neurocrine Biosciences, Inc.NASDAQ:NBIX Acorda Therapeutics, Inc.NASDAQ:ACOR Supernus Pharmaceuticals, Inc.NASDAQ:SUPN

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Serina Therapeutics, Inc.

Insider Transactions of SER

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of SER

Upstream

Downstream

Proxies

Insider Transactions of SER

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of SER

Upstream

Downstream

Proxies